Stocks and Investing Stocks and Investing
Thu, March 7, 2024
Wed, March 6, 2024

Andrew Mok Initiated (AGL) at Sell and Held Target at $5 on, Mar 6th, 2024


Published on 2024-10-28 09:30:38 - WOPRAI, Andrew Mok
  Print publication without navigation


Andrew Mok of Barclays, Initiated "agilon health, inc." (AGL) at Sell and Held Target at $5 on, Mar 6th, 2024.

Andrew has made no other calls on AGL in the last 4 months.



There are 12 other peers that have a rating on AGL. Out of the 12 peers that are also analyzing AGL, 8 agree with Andrew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jailendra Singh of "Truist Securities" Maintained at Hold with Decreased Target to $7.5 on, Thursday, February 29th, 2024
  • Elizabeth Anderson of "Evercore ISI Group" Maintained at Hold with Decreased Target to $6 on, Wednesday, February 28th, 2024
  • Gary Taylor of "TD Cowen" Downgraded from Buy to Hold and Decreased Target to $6.5 on, Monday, February 26th, 2024
  • Craig Jones of "Stifel" Maintained at Hold with Decreased Target to $9 on, Thursday, February 22nd, 2024
  • Justin Lake of "Wolfe Research" Downgraded from Buy to Hold on, Monday, January 8th, 2024
  • Lisa Gill of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $9 on, Friday, January 5th, 2024
  • Jamie Perse of "Goldman Sachs" Downgraded from Strong Buy to Hold on, Monday, December 11th, 2023
  • George Hill of "Deutsche Bank" Downgraded from Strong Buy to Hold and Decreased Target to $12 on, Tuesday, November 21st, 2023


These are the ratings of the 4 analyists that currently disagree with Andrew


  • Bill Sutherland of "Benchmark" Maintained at Strong Buy with Decreased Target to $9 on, Thursday, February 29th, 2024
  • Sean Dodge of "RBC Capital" Maintained at Buy with Decreased Target to $8 on, Wednesday, February 28th, 2024
  • Stephen Baxter of "Wells Fargo" Maintained at Buy with Decreased Target to $8 on, Monday, February 26th, 2024
  • Constantine Davides of "JMP Securities" Initiated at Buy and Held Target at $18 on, Wednesday, December 6th, 2023
Contributing Sources